Endoscopic surveillance in serrated polyposis syndrome: a randomized controlled trial comparing two- vs. three-year colonoscopy intervals

Endoscopy 2025; 57(S 02): S11
DOI: 10.1055/s-0045-1805107

Abstracts | ESGE Days 2025

Oral presentation

WEO Joint session: Current status of screening methods for CRC 03/04/2025, 09:00 – 10:00 Room 114

Authors

References
1 Crockett SD, Nagtegaal ID.. Terminology, molecular features, epidemiology, and management of serrated colorectal neoplasia. Gastroenterology 2019; 157 (04): 949-66. e4
2 van Leerdam ME, Roos VH, van Hooft JE, Dekker E, Jover R, Kaminski MF. et al. Endoscopic management of polyposis syndromes: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy 2019; 51: 877-95
3 Dekker E, Bleijenberg A, Balaguer F, IJspeert JEG, Bleijenberg AGC, Pellisé M. et al. Update on the World Health organization criteria for diagnosis of serrated polyposis syndrome. Gastroenterology 2020; 158 (06): 1520-3
4 Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P. et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76 (02): 182-8
5 Rodríguez-Alcalde D., Castillo-López G., López-Vicente J., Hernández L., Lumbreras-Cabrera M., Moreno-Sánchez D.. Long-Term Incidence of Advanced Colorectal Neoplasia in Patients with Serrated Polyposis Syndrome: Experience in a Single Academic Centre. Cancers 2021; 13: 1066
6 Bleijenberg AGC, IJspeert JEG, van Herwaarden YJ. et al. Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study. Gut 2020; 69: 112-121